Stock detail

Natera (NTRA) stock price, chart, and key data

View Natera stock price, chart movement, and headline metrics on Woodstock's stock detail page.

NTRA

Stock detail

Natera

NTRA · XNAS

-$6.60 (-2.47%) past day

$260.90

Overnight $261.17 (+0.10%)

XNAS24/5 tradingLast updated: Jul 25, 01:01 PM

Key metrics

Financials

Quarterly revenue, profitability, and balance-sheet snapshot

0.360.09-0.19-0.46-0.74
FY2025 Q2Reported Revenue: $547MExpected Revenue: $477MNet income: -$101MExpected EPS: -0.74
FY2025 Q3Reported Revenue: $592MExpected Revenue: $515MNet income: -$88MExpected EPS: -0.64
FY2025 Q4Reported Revenue: $665MExpected Revenue: $603MNet income: $47MReported EPS: 0.34Expected EPS: 0.36
FY2026 Q1Reported Revenue: $697MExpected Revenue: $617MNet income: -$85MExpected EPS: -0.60
FY2026 Q2Expected Revenue: $661M
FY2026 Q3Expected Revenue: $694M
696.6M537.1M377.6M218.1M58.6M-100.9M
FY25 Q2Q3Q4FY26 Q1Q2Q3

Operating income & Operating cash flow

Quarterly revenue, profitability, and balance-sheet snapshot

73.9M37M184K-36.7M-73.5M-110.4M
FY2024 Q4Operating income: -$65MOperating cash flow: $53M
FY2025 Q1Operating income: -$79MOperating cash flow: $44M
FY2025 Q2Operating income: -$110MOperating cash flow: $38M
FY2025 Q3Operating income: -$98MOperating cash flow: $59M
FY2025 Q4Operating income: -$23MOperating cash flow: $74M
FY2026 Q1Operating income: -$86MOperating cash flow: $40M
FY24 Q4FY25 Q1Q2Q3Q4FY26 Q1

Total assets & Total liabilities

Quarterly revenue, profitability, and balance-sheet snapshot

2.6B2.1B1.6B1B522.9M0
FY2024 Q4Total assets: $2BTotal liabilities: $465M
FY2025 Q1Total assets: $2BTotal liabilities: $493M
FY2025 Q2Total assets: $2BTotal liabilities: $511M
FY2025 Q3Total assets: $2BTotal liabilities: $569M
FY2025 Q4Total assets: $2BTotal liabilities: $686M
FY2026 Q1Total assets: $3BTotal liabilities: $840M
FY24 Q4FY25 Q1Q2Q3Q4FY26 Q1

Total equity & Shares outstanding

Quarterly revenue, profitability, and balance-sheet snapshot

1.8B1.4B1.1B709.6M354.8M0
FY2024 Q4Total equity: $1BShares outstanding: 135.2M
FY2025 Q1Total equity: $1BShares outstanding: 136.5M
FY2025 Q2Total equity: $1BShares outstanding: 137.2M
FY2025 Q3Total equity: $1BShares outstanding: 138M
FY2025 Q4Total equity: $2BShares outstanding: 141.7M
FY2026 Q1Total equity: $2BShares outstanding: 143.2M
FY24 Q4FY25 Q1Q2Q3Q4FY26 Q1

Day range

$259.00 - $271.71

52-week range

$131.81 - $288.04

Close price

$264.69

Market cap

$37.9B

P/E ratio

-434.83

Beta

1.51

Financials

FY2026 Q1

Operating income

-$86M

Operating cash flow

$40M

EPS

Shares outstanding

143.2M

Total assets

$3B

Total equity

$2B

Total liabilities

$840M

About the company

Natera Inc

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

Analyst rating summary

A current read on analyst sentiment from the insight feed.

Mean target

$281

Current price $261
Low$220High$330

17

Buy

/ 19

Recent calls

07/17/2026

Piper Sandler

David Westenberg

Buy · Price target $249

07/14/2026

Goldman Sachs

Evie Koslosky

Hold · Price target $270

07/15/2026

TD Cowen

Daniel Brennan

Buy · Price target $325

Ticker holders

Review politician disclosures and insider transactions in tabs.

Holder directory

Select a heading to reorder by name, activity date, buy/sell, or displayed value.

4/4

#1Dan Goldman

democrat · House · NY-10

self
  • Sell$1,000 / $8,000 / $15,000
  • Buy$1,000 / $8,000 / $15,000
$2,000/$16,000/$30,000

#2Bill Hagerty

republican · Senate · TN

self
  • Sell$1,001 / $8,001 / $15,000
  • Sell$1,000 / $8,000 / $15,000
1,105/631/1,579

#3Josh Gottheimer

democrat · House · NJ-5

joint
  • Buy$1,001 / $8,001 / $15,000
  • Buy$1,001 / $8,001 / $15,000
  • Sell$1,001 / $8,001 / $15,000
  • Buy$1,000 / $8,000 / $15,000
92/11/174

#4Donald J Trump

republican · Executive

self
2026
28/3/54

Market action

A concise summary of the latest filing, transaction, or market-moving item.

Latest EDGAR 4 filed on 2026-07-17, report date 2026-07-15: Sheena Jonathan / Natera, Inc. reports ownership changes; on 07/15/2026; in Common Stock; including 246,202 shares at 450 per share; 18,332 shares at 274.2589 per share; 18,242 shares at 170 per share; 18,072 shares at 276.38 per share; 18,032 shares at 390 per share; 18,392 shares at 100 per share; 18,292 shares at 180 per share; 18,112 shares at 276.015 per share; 1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. 2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.56 to $273.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. 4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.87 to $274.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.99 to $275.65 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.56 to $273.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 7. The reported price in Column 4 is a weighted average price.

24/5 Trading

Act on the stock when the timing works for you.

With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.

*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.

Download the app
24/5 trading chart preview

Sign Up

Scan the QR code to get started

Contact via LINE

Scan the QR code to get started

LINE QR Code